Free Trial

Relx Plc (NYSE:RELX) Shares Purchased by Dimensional Fund Advisors LP

Relx logo with Computer and Technology background

Dimensional Fund Advisors LP grew its holdings in Relx Plc (NYSE:RELX - Free Report) by 4.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,189,886 shares of the technology company's stock after acquiring an additional 121,831 shares during the period. Dimensional Fund Advisors LP owned about 0.17% of Relx worth $144,885,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in RELX. Virtu Financial LLC purchased a new position in Relx in the third quarter valued at about $223,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Relx in the third quarter worth about $125,000. Peapack Gladstone Financial Corp boosted its position in shares of Relx by 5.7% in the third quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company's stock worth $234,000 after buying an additional 267 shares during the period. Franklin Resources Inc. boosted its position in shares of Relx by 3.3% in the third quarter. Franklin Resources Inc. now owns 18,429 shares of the technology company's stock worth $873,000 after buying an additional 588 shares during the period. Finally, JPMorgan Chase & Co. boosted its position in shares of Relx by 14.6% in the third quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company's stock worth $39,225,000 after buying an additional 104,999 shares during the period. Institutional investors and hedge funds own 15.02% of the company's stock.

Relx Stock Performance

Shares of Relx stock traded up $0.23 on Wednesday, reaching $54.02. 240,471 shares of the company were exchanged, compared to its average volume of 706,489. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The company's 50-day moving average is $49.66 and its two-hundred day moving average is $48.33. The firm has a market cap of $99.98 billion, a price-to-earnings ratio of 29.08, a P/E/G ratio of 2.73 and a beta of 0.84. Relx Plc has a 1-year low of $40.77 and a 1-year high of $54.22.

Relx Increases Dividend

The firm also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be given a $0.5586 dividend. This is a boost from Relx's previous semi-annual dividend of $0.23. This represents a yield of 1.6%. The ex-dividend date is Friday, May 9th. Relx's dividend payout ratio (DPR) is currently 59.68%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on RELX shares. StockNews.com downgraded Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. The Goldman Sachs Group started coverage on Relx in a report on Wednesday, March 26th. They set a "buy" rating on the stock. Finally, Redburn Atlantic started coverage on Relx in a research report on Wednesday, January 8th. They set a "buy" rating on the stock. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Buy".

Read Our Latest Report on RELX

About Relx

(Free Report)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Recommended Stories

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Should You Invest $1,000 in Relx Right Now?

Before you consider Relx, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.

While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines